Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Study of ABT-652 in Adults With Osteoarthritis Pain of the Knee

ClinicalTrials.gov ID: NCT01207115

Public ClinicalTrials.gov record NCT01207115. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 28, 2026, 6:43 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Global Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled Study Comparing the Analgesic Efficacy and Safety of ABT-652 to Placebo in Subjects With Osteoarthritis Pain of the Knee

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To compare the analgesic efficacy and safety of ABT-652 administered twice daily (BID) to placebo in subjects with osteoarthritis (OA) of the knee.

Study identification

NCT ID
NCT01207115
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
AbbVie (prior sponsor, Abbott)
Industry
Enrollment
322 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
40 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 2010 (Type not available)
Primary completion
May 2011 (Actual)
Completion
May 2011 (Actual)
Last update posted
Jan 7, 2013

2010 – 2011

United States locations

U.S. sites
23
U.S. states
12
U.S. cities
23
Facility City State ZIP Site status
Site Reference ID/Investigator# 37220 Chandler Arizona 85224 —
Site Reference ID/Investigator# 37223 Tempe Arizona 85282 —
Site Reference ID/Investigator# 37215 Tucson Arizona 85704 —
Site Reference ID/Investigator# 37221 Anaheim California 92801 —
Site Reference ID/Investigator# 37222 Burbank California 91505 —
Site Reference ID/Investigator# 35956 Chino California 91710 —
Site Reference ID/Investigator# 37053 La Mesa California 91942 —
Site Reference ID/Investigator# 37218 Lomita California 90717 —
Site Reference ID/Investigator# 37227 Milford Connecticut 06460 —
Site Reference ID/Investigator# 37229 Boynton Beach Florida 33472 —
Site Reference ID/Investigator# 37209 Ocala Florida 34471 —
Site Reference ID/Investigator# 37212 Plantation Florida 33317 —
Site Reference ID/Investigator# 35961 South Miami Florida 33143 —
Site Reference ID/Investigator# 37207 Valparaiso Indiana 46383 —
Site Reference ID/Investigator# 37217 Brooklyn Center Minnesota 55430 —
Site Reference ID/Investigator# 37228 St Louis Missouri 63141 —
Site Reference ID/Investigator# 35959 New York New York 10004 —
Site Reference ID/Investigator# 37211 Salisbury North Carolina 28144 —
Site Reference ID/Investigator# 37214 Duncansville Pennsylvania 16635 —
Site Reference ID/Investigator# 37205 Wyomissing Pennsylvania 19610 —
Site Reference ID/Investigator# 37208 Austin Texas 78705 —
Site Reference ID/Investigator# 37213 San Antonio Texas 78209-1744 —
Site Reference ID/Investigator# 35953 Richmond Virginia 23294 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 15 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01207115, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 7, 2013 · Synced Oct 28, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01207115 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →